Evidence map›Paper›PMID 32464582›Full record

ArticleMultiple sclerosis and related disorders2020

Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations.

Carlos Guevara, Eduardo Villa, Carlos Silva Rosas, Violeta Diaz, Rodrigo Naves

Abstract readLetter
In one paragraph

Article in Multiple sclerosis and related disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. COVID-19 illness and autoimmune diseases: recent insights.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carlos GuevaraFaculty of Medicine, Hospital Clínico José Joaquín Aguirre, Universidad de Chile, Santos Dumont 999, Santiago, Chile. Electronic address: cguevara@hcuch.cl.
Eduardo VillaFaculty of Medicine, Hospital Clínico José Joaquín Aguirre, Universidad de Chile, Santos Dumont 999, Santiago, Chile.
Carlos Silva RosasFaculty of Medicine, Hospital Clínico José Joaquín Aguirre, Universidad de Chile, Santos Dumont 999, Santiago, Chile.
Violeta DiazFaculty of Medicine, Hospital Clínico José Joaquín Aguirre, Universidad de Chile, Santos Dumont 999, Santiago, Chile.
Rodrigo NavesInstitute of Biomedical Science, Faculty of Medicine, Universidad de Chile. Electronic address: rodrigonaves@uchile.cl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health BehaviorQuarantineAdultAlemtuzumabAntibodies, Monoclonal, HumanizedBetacoronavirusChileCoronavirus InfectionsCOVID-19Decision MakingFemaleFingolimod HydrochlorideGlatiramer AcetateGuideline AdherenceGuidelines as TopicHumansAlemtuzumabAntibodies, Monoclonal, HumanizedFingolimod HydrochlorideGlatiramer AcetateImmunologic FactorsInterferonsNatalizumabocrelizumab

Identifiers

PMID32464582
PMCPMC7245233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.